Skip to main content
. 2025 Jul 25;104(8):4071–4080. doi: 10.1007/s00277-025-06426-7

Table 2.

Semen parameters at various time points (from baseline to > 5 years from the end of treatment) of the patients who we have available follow-up data

T0 T1 T2 T3 T4 T5 T > 5 p-value2
Total Sperm Number (x106/ejac.) 309 ± 350.3 (150) 300.0 ± NA (300.0) 125.9 ± 196.1 (24) 64.2 ± 93.3 (18) 113.2 ± 96.3 (112) 47 ± 26.9 (47) 15 ± 18.2 (14) 0.364
Progressive Motility (%) 39.2 ± 12.4 (40) 55.0 ± NA (55.0) 26.7 ± 25.2 (30) 30 ± 22.9 (25) 41.7 ± 18.9 (50) 30 ± NA (30) 14.2 ± 16.1 (15) 0.056
Abnormal forms (%) 86.2 ± 8.4 (88) 87.0 ± NA (87.0) 94 ± 5.6 (93) 82.0 ± 6.6 (83) 87.3 ± 5 (88) 90.5 ± 3.5 (90.5) 96.0 ± 4.4 (97) 0.116

1 Mean ± SD (Median)

2Kruskal-Wallis rank sum test; Fisher’s exact test